Fannin Advances Ewing Sarcoma Therapy With New Grants
Houston, Texas, August 14, 2026 Fannin Partners, LLC has received new grants from the Congressionally Directed Medical Research Programs...
Biomarkers
Advertisement
Insilico and THPharm Expand AI Drug Development Strategy
Seoul, South Korea, August 12, 2026 THPharm is advancing an artificial intelligence-driven indication expansion strategy in partnership with Insilico...
Annovis Advances Buntanetap in Alzheimer’s Phase 3
Malvern, Pennsylvania — August 14, 2026 Annovis Bio, Inc. announced that its pivotal Phase 3 Alzheimer’s disease trial of...
Lupus Foundation Awards Grants to Advance Targeted Research
New York and Massachusetts, USA, August 14, 2026 The Lupus Foundation of America has announced the recipients of its...
SK bioscience Advances RSV Antibody Clinical Development
Seongnam, South Korea, August 14, 2026 SK bioscience has submitted a Clinical Trial Application (CTA) to the South African...
Advertisements
Genedata Advances AI Biomarker Discovery in Alzheimer’s Research
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
AC Immune Receives FDA Fast Track Designation for ACI-7104 in Parkinson’s
LAUSANNE, Switzerland, August 11, 2026 AC Immune SA announced that the U.S. Food and Drug Administration (FDA) has granted...
Clene Advances CNM-Au8 Toward ALS Accelerated Approval
SALT LAKE CITY, Utah, August 10, 2026 Clene Inc. announced new biomarker analyses for CNM-Au8 that will be included...
Ernexa Therapeutics Advances ERNA-101 Toward Phase 1 Trial
Cambridge, Massachusetts, August 10, 2026 Ernexa Therapeutics announced the appointment of David Polinsky to its Board of Directors as...
Genome BC Advances Genomic Health Research in British Columbia
Vancouver, British Columbia, August 11, 2026 Genome BC has announced six research projects supported through its Data Access, Integration...
Advertisement
